| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2812 | |||||||||||||||||||||||
| Submitter : | Mrs. Jennifer Bolt | Date & Time: | 12/08/2006 09:12:52 | |||||||||||||||||||||
| Organization : | Mrs. Jennifer Bolt | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I believe that the use of human aborted fetus cell lines for pharmaceuticals and research is both unethical and unnecessary! I will NEVER purchase ANY pharmaceutical products from a company that engages in this practice. | ||||||||||||||||||||||||